Abbott Treasury Stock increased by 1.8% to $17.18B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.0%, from $16.84B to $17.18B. Over 5 years (FY 2020 to FY 2025), Treasury Stock shows an upward trend with a 11.3% CAGR.
An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.
Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...
Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.
treasury_stock| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.34B | $11.00B | $11.82B | $13.73B | $13.72B | $14.56B | $15.23B | $15.31B | $15.72B | $15.69B | $15.98B | $15.76B | $15.76B | $16.48B | $16.84B | $16.61B | $16.61B | $16.88B | $17.18B |
| QoQ Change | — | +6.4% | +7.5% | +16.1% | -0.0% | +6.1% | +4.6% | +0.5% | +2.7% | -0.2% | +1.9% | -1.4% | -0.0% | +4.5% | +2.2% | -1.4% | -0.0% | +1.6% | +1.8% |
| YoY Change | — | — | — | — | +32.7% | +32.3% | +28.8% | +11.5% | +14.6% | +7.8% | +4.9% | +3.0% | +0.2% | +5.0% | +5.4% | +5.4% | +5.4% | +2.4% | +2.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.